tiprankstipranks
Absci price target lowered to $5 from $6 at KeyBanc
PremiumThe FlyAbsci price target lowered to $5 from $6 at KeyBanc
10d ago
Absci, Invetx partner to bring AI drug creation platform to animal health
Premium
The Fly
Absci, Invetx partner to bring AI drug creation platform to animal health
12d ago
Absci highlights progress, updates across proprietary pipeline
Premium
The Fly
Absci highlights progress, updates across proprietary pipeline
1M ago
Absci management to meet virtually with KeyBanc
PremiumThe FlyAbsci management to meet virtually with KeyBanc
2M ago
Absci Corporation Advances AI-Driven Drug Development
Premium
Company Announcements
Absci Corporation Advances AI-Driven Drug Development
2M ago
Absci reports Q3 EPS (24c), consensus (21c)
Premium
The Fly
Absci reports Q3 EPS (24c), consensus (21c)
2M ago
Absci, Twist Bioscience collaborate to design antibody using generative AI
PremiumThe FlyAbsci, Twist Bioscience collaborate to design antibody using generative AI
3M ago
Cathie Wood’s ARK Investment bought 401K shares of Absci today
Premium
The Fly
Cathie Wood’s ARK Investment bought 401K shares of Absci today
3M ago
Cathie Wood’s ARK Investment bought 447K shares of Absci today
Premium
The Fly
Cathie Wood’s ARK Investment bought 447K shares of Absci today
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100